PCAS has four ISO 9001 manufacturing sites with production facilities dedicated to its activities.
The Group has consolidated on technology platforms on which considerable experience has been developed:
- Cost-effective production of intermediates and building blocks.
- Total reactor capacity of 400 m3.
- Back-integration for pharma key starting materials.
- Custom Manufacturing Services.
- Regulatory starting materials.
- Access to complementary technology platforms and chemical development expertise. Central R&D department in HQ (Longjumeau) and pilot plant facilities for scale-up.
